Literature DB >> 3158512

Epilepsy, sex hormones, and antiepileptic drugs.

R H Mattson, J A Cramer.   

Abstract

Many factors associated with hormone function have an impact on the course of epilepsy. Patients with epilepsy may have disturbances in sexual function such as anovulatory cycles in women and decreased libido and potency in men. Data indicate seizures, especially those arising in the limbic system, may influence the hypothalamic pituitary axis. Antiepileptic drugs also influence sexual function through direct brain effects as well as through induced changes in pharmacokinetics of the sex steroid hormones. Pregnancy has been reported to be a time of increased seizures; however, this has often been associated with low drug levels, for reasons that include inadequate drug dose, possible changes in pharmacokinetics, and noncompliance. Some evidence suggests that hormones affect seizure frequency. Changes in seizures during the menstrual cycle (catamenial epilepsy) have been found in some women: seizures were fewer during the luteal phase but increased when progesterone levels declined. Some improvement in seizure frequency has been shown in pilot studies using medroxyprogesterone acetate, a synthetic progesterone. Current concepts of the interrelationship among epilepsy, sex hormones, and antiepileptic drugs are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158512     DOI: 10.1111/j.1528-1157.1985.tb05723.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

1.  The antiepileptic effect of sodium valproate during different phases of the estrous cycle in PTZ-induced seizures in rats.

Authors:  Jahangir Kaboutari; Morteza Zendehdel; Saeed Habibian; Mahmood Azimi; Mohammad Shaker; Behnaz Karimi
Journal:  J Physiol Biochem       Date:  2011-11-11       Impact factor: 4.158

2.  Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects.

Authors:  J G Larkin; P J McKee; G Forrest; G H Beastall; B K Park; J I Lowrie; P Lloyd; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 3.  Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.

Authors:  A D Kashuba; A N Nafziger
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

4.  Circulating levels of anticonvulsant metabolites of progesterone in women with partial epilepsy in the intercritical phase.

Authors:  R Galli; S Michelini; L Bartalena; R Massetani; L Pani; L Grasso; G B Cassano; E Martino; R H Purdy; L Murri
Journal:  Ital J Neurol Sci       Date:  1996-08

5.  Effects of carbamazepine on the first ovulation in gonadotropin-primed immature female rats.

Authors:  K Tamura; Y Yatabe; H Sakamoto; M Hosokawa; K Kobayashi; K Chiba; H Kogo
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

Review 6.  Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy.

Authors:  Jouko I T Isojärvi; Erik Taubøll; Andrew G Herzog
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 7.  Influence of sex hormones on brain excitability and epilepsy.

Authors:  A Verrotti; G Latini; R Manco; M De Simone; F Chiarelli
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

8.  Development of spike-wave seizures in C3H/HeJ mice.

Authors:  Damien J Ellens; Ellie Hong; Kathryn Giblin; Matthew J Singleton; Chhitij Bashyal; Dario J Englot; Asht M Mishra; Hal Blumenfeld
Journal:  Epilepsy Res       Date:  2009-05-05       Impact factor: 3.045

9.  Potentiation of the depression by adenosine of rat cerebral cortical neurones by progestational agents.

Authors:  J W Phillis
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

10.  Pregnancy and epilepsy.

Authors:  S Bag; M Behari; G K Ahuja; M G Karmarkar
Journal:  J Neurol       Date:  1989-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.